These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 28349504)

  • 61. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
    Yu SY; Nam DH; Lee DY
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correlation of Macular Thickness and Visual Acuity in DME Treated by Two Doses of Intravitreal Ziv-Aflibercept Versus Bevacizumab: Analysis of a Randomized, Three-Armed Clinical Trial.
    Jabbarpoor Bonyadi MH; Baghi A; Ramezani A; Yaseri M; Soheilian M
    Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):684-690. PubMed ID: 31755967
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Meta-analysis and review on the effect of bevacizumab in diabetic macular edema.
    Goyal S; Lavalley M; Subramanian ML
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):15-27. PubMed ID: 20665044
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Dabour SA
    Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S
    BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema.
    Yilmaz T; Cordero-Coma M; Gallagher MJ; Teasley LA
    Acta Ophthalmol; 2011 Dec; 89(8):709-17. PubMed ID: 20645926
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial.
    Shoeibi N; Ahmadieh H; Entezari M; Yaseri M
    J Ophthalmic Vis Res; 2013 Apr; 8(2):99-106. PubMed ID: 23943683
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up.
    Arevalo JF; Sanchez JG; Fromow-Guerra J; Wu L; Berrocal MH; Farah ME; Cardillo J; Rodríguez FJ;
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):735-43. PubMed ID: 19189118
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series.
    Nicolò M; Nasciuti F; Lai S; Ghiglione D; Borgia L; Calabria G
    Eur J Ophthalmol; 2006; 16(1):129-33. PubMed ID: 16496256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
    Lee HY; Lee SY; Park JS
    Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
    Kuley B; Storey PP; Wibbelsman TD; Pancholy M; Zhang QE; Sharpe J; Bello N; Obeid A; Regillo C; Kaiser RS; Chiang A; Fineman MS; Vander JF; Gupta OP; Spirn MJ; Dunn JP; Mehta S; Park CH; Maguire JI; Garg S
    Curr Eye Res; 2021 Jun; 46(6):824-830. PubMed ID: 33522311
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema.
    Sobaci G; Ozge G; Erdurman C; Durukan HA; Bayraktar ZM
    Ophthalmologica; 2012; 227(2):95-9. PubMed ID: 21893972
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment.
    Hong IH; Choi W; Han JR
    Jpn J Ophthalmol; 2020 Mar; 64(2):196-202. PubMed ID: 31900869
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.